Get four, well-researched articles on the possibilities of metabolomics to tackle different aspects of the global pandemic within the next week.

Article 1: Interaction of COVID-19 and metabolic disease

Article 2: Long-term outcome after a COVID-19 infection

Article 3: Animal models for COVID-19 research

Article 4: Metabolomics and response to SARS-CoV-2 vaccination

Sars-CoV-2 is a novel coronavirus. Thus, the biology is not well characterized yet. Among the issues that we need to understand better are the factors that contribute to the heterogenic outcomes of COVID-19, and the reasons that put elderly populations at increased risk of severe disease courses. Against this backdrop, biomarkers that can be predictive of probable disease progression or the response to a specific course of therapy would be highly valuable to personalize treatments at every stage of the disease.